Business Context and Reporting Period
This Form 8-K Current Report was filed by MYOMO, INC. on February 21, 2024. The filing discloses amendments to employment and severance agreements for two key executive officers: David Henry, Chief Financial Officer, and Harry Kovelman, Chief Medical Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The filing details the following material changes to executive compensation effective February 21, 2024:
- David Henry (CFO): Entered into an amended employment agreement setting a base salary of $260,000. He is eligible for annual incentive compensation of up to 55% of his base salary. The amendment includes provisions for the immediate acceleration of all time-based and performance-based stock awards in the event of a termination without cause within 12 months of a change in control.
- Harry Kovelman (CMO): Entered into an amended and restated change of control and severance agreement. In the event of termination without cause, he is entitled to:
- 50% of his annual salary plus a pro-rata portion of his annual incentive bonus.
- Monthly cash payments for six months (or the COBRA period, whichever is shorter) covering employer health insurance contributions.
- Vesting of stock options and awards that would have vested over an additional six months.
- If termination without cause occurs within 12 months of a change in control, the severance payment period extends to nine months, and all time-based and performance-based stock awards accelerate immediately.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or general risk factors. The primary contingency disclosed relates to the financial obligations triggered by a "change in control" or "termination without cause" for the named executives, specifically regarding accelerated equity vesting and severance payments.
Investor Verification Checklist
- Verify the total potential cash and equity liability associated with the "change in control" acceleration clauses for Mr. Henry and Mr. Kovelman.
- Review the full text of Exhibit 10.1 (Henry Amendment) and Exhibit 10.2 (Kovelman Agreement) for specific definitions of "termination without cause" and "change in control."
- Confirm the current outstanding stock option and award balances for both executives to assess the magnitude of potential acceleration.
- Check subsequent filings for any actual terminations or change in control events that would trigger these provisions.